- Home
- RFIL vs RNTX Comparison
RFIL vs RNTX Comparison
Compare RFIL & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- RNTX
- Stock Information
- Founded
- RFIL 1979
- RNTX 2001
- Country
- RFIL United States
- RNTX United States
- Employees
- RFIL N/A
- RNTX N/A
- Industry
- RFIL Electrical Products
- RNTX Biotechnology: Pharmaceutical Preparations
- Sector
- RFIL Technology
- RNTX Health Care
- Exchange
- RFIL Nasdaq
- RNTX Nasdaq
- Market Cap
- RFIL 39.9M
- RNTX 44.2M
- IPO Year
- RFIL N/A
- RNTX N/A
- Fundamental
- Price
- RFIL $3.82
- RNTX $1.70
- Analyst Decision
- RFIL Strong Buy
- RNTX
- Analyst Count
- RFIL 1
- RNTX 0
- Target Price
- RFIL $4.50
- RNTX N/A
- AVG Volume (30 Days)
- RFIL 38.1K
- RNTX 26.3K
- Earning Date
- RFIL 06-12-2025
- RNTX 04-07-2025
- Dividend Yield
- RFIL N/A
- RNTX N/A
- EPS Growth
- RFIL N/A
- RNTX N/A
- EPS
- RFIL N/A
- RNTX N/A
- Revenue
- RFIL $70,599,000.00
- RNTX N/A
- Revenue This Year
- RFIL $16.16
- RNTX N/A
- Revenue Next Year
- RFIL $5.75
- RNTX N/A
- P/E Ratio
- RFIL N/A
- RNTX N/A
- Revenue Growth
- RFIL 4.93
- RNTX N/A
- 52 Week Low
- RFIL $2.86
- RNTX $1.35
- 52 Week High
- RFIL $5.77
- RNTX $7.42
- Technical
- Relative Strength Index (RSI)
- RFIL 40.43
- RNTX N/A
- Support Level
- RFIL $3.76
- RNTX N/A
- Resistance Level
- RFIL $4.17
- RNTX N/A
- Average True Range (ATR)
- RFIL 0.30
- RNTX 0.00
- MACD
- RFIL -0.05
- RNTX 0.00
- Stochastic Oscillator
- RFIL 28.48
- RNTX 0.00
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.
About RNTX Rein Therapeutics Inc. Common Stock
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03, LTI-01, and others.